The diagnostic accuracy of the PSA density calculated using either the TRUS or MRI showed no significant difference in predicting any-grade prostate cancer (p = 0.985) or csPCa (p = 0.856) (Figure 3). This evidence concerns the gene KLK3 and prostate carcinoma.